tradingkey.logo

BRIEF-Abbvie And Xilio Therapeutics Announce Collaboration

ReutersFeb 12, 2025 12:41 PM

- Abbvie ABBV.N:

  • ABBVIE AND XILIO THERAPEUTICS ANNOUNCE COLLABORATION AND OPTION AGREEMENT TO DEVELOP NOVEL TUMOR-ACTIVATED IMMUNOTHERAPIES

  • ABBVIE INC - COLLABORATION TO DEVELOP MASKED T-CELL ENGAGERS

  • ABBVIE INC - XILIO TO RECEIVE $52 MILLION UPFRONT, ELIGIBLE FOR UP TO $2.1 BILLION

Source text: ID:nPn9Fv6m9a

Further company coverage: ABBV.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI